
Venous thromboembolism risk up with cisplatin-based chemo
(HealthDay)—Patients with advanced solid tumors receiving cisplatin-based chemotherapy regimens have a significantly higher risk of having a venous thromboembolic event (VTE) compared with those who do not receive a cisplatin-based ...
Nov 15, 2012
0
0